|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Respiratory Medicine, Bristol Royal Infirmary, Bristol, England.
Correspondence to: Adrian H. Kendrick, PhD, Department of Respiratory Medicine, Bristol Royal Infirmary, Bristol BS2 8HW, England; e-mail: adrian.kendrick{at}ubht.swest.nhs.uk
| Abstract |
|---|
|
|
|---|
Study Objectives: To compare a pulse oximeter used at home with an 8-h memory, storing data every 12 s, and in the laboratory, with on-line recording every 2 s.
Design: Prospective cohort study.
Setting: Patients homes and a sleep laboratory.
Patients: One hundred patients with suspected SAHS.
Measurements: Home oximetry and a
laboratory full polysomnography. The number of
4% dips in pulse
oximetric saturation (SpO2) was calculated for
each study. Daytime sleepiness was assessed by the Epworth Sleepiness
Scale (ESS) score.
Results: The mean dips per hour were 5.3/h (range, 0 to 53/h) for home studies and 13.4/h (range, 0 to 106/h) for laboratory studies; the relationship between home and laboratory studies was as follows: home = (0.4 x laboratory) - 0.01 ± 11.2; r2 = 0.64. Mean difference was 8.4/h (- 2.5 to + 77.9/h), which correlated with the mean of the measurements. At a cutoff point of 10/h, 52 studies were both negative and 13 studies were both positive. Nineteen home studies were false-negatives. Sensitivity was 0.41, and specificity was 1.0. In these 19 studies, 7 patients had an ESS score > 10 and 4 patients had an ESS score > 14. To confirm that differences were due to different sampling rates, 16 additional patients had on-line data and stored data collected simultaneously in the laboratory. Mean dips per hour were 3.2/h (range, 0.1 to 18.3/h) for the stored data and 8.34/h (0.2 to 22.8/h) for on-line data; the relationship being stored was as follows: 0.5 on-line - 1.17 ± 2.6; r2 = 0.69. Mean difference was 5.2/h (0.04 to 15.4 h), which correlated with the mean of the measurements.
Conclusion: Home studies using a memory storage pulse oximeter may underestimate the number of hypoxic dips, probably due to sampling rates. Clinically significant hypoxic SAHS may therefore be missed.
Key Words: polysomnography pulse oximetry sleep apnea
| Introduction |
|---|
|
|
|---|
To be useful as a diagnostic tool in the home, a pulse oximeter should
have a memory storage capability. There are few studies in adults and
none in children to our knowledge assessing whether pulse oximeters
used for home studies adequately reflect that which is observed in the
laboratory. Warley et al7
demonstrated, using simulated
computer-generated signals, that Biox pulse oximeters are
adequate for assessing SAHS. However, we have observed that there is a
discrepancy between the number of falls in
SpO2 of
4% obtained from home
studies and from on-line recordings in the laboratory using similar
oximeters.
| Materials and Methods |
|---|
|
|
|---|
Pulse Oximeter
The oximeters used in this study were the Biox 3740 (Ohmeda;
UK). For the home and laboratory studies, the oximeters were
identical, including the software version (version 9) and the default
settings. Signal averaging defaulted to 6 s in this software
version. A finger-clip oximeter probe was used in all studies. These
oximeters have a memory storage capability of 8 h, storing a data
point every 12 s. This memory capability was used in the home
studies and some of the laboratory studies for comparison. Recordings
online in the laboratory studies recorded a data point every 2 s.
These oximeters also have pulse waveforms that provide an indication of
signal strength. It was not possible to evaluate whether good signal
strength was obtained in the home studies. In the laboratory studies,
the pulse waveform was monitored throughout the night to ensure good
quality signal strength.
Home Studies
Patients were loaned an oximeter to use overnight at home. They
were instructed to behave normally, retiring to bed at their usual time
and rising as normal, and they were asked to record if they had
consumed alcohol and whether they had had a normal nights sleep. They
were shown how to set up the oximeter and how to disable the pulse
volume and low-saturation alarms. On return, the 8-h memory was
downloaded into the CNS SleepLab Laboratory system (Erich Jaeger;
UK) for analysis. A download program was written in-house
specifically to retrieve data from the oximeter memory, so that it
could be analyzed using the CNS SleepLab analysis suite.
Laboratory Studies
Three studies were performed.
Study 1: This study was performed to determine whether any differences existed between the in-housedeveloped download programs on the CNS system analysis software. We studied 16 patients and compared the results from the CNS system analysis to another, previously validated, commercially available analysis package run on a BBC-B computer. The memory of the oximeter was downloaded into the CNS system analysis software and into a BBC-B computer. The BBC-B produced a printout and analysis of 4% dips in SaO2 in 8 sequential hours.9
Study 2: Within 3 days of the home study, patients underwent a full polysomnographic study that included EEG, electro-oculography, electromyography, and ECG recordings, thoracoabdominal and nasal-oral airflow measurements, and pulse oximetry.10 The signals were recorded on-line using the SleepLab system. Video sound recording was made throughout the night. Patients went to bed at their normal bedtime; if they consumed alcohol on their home study night, they were allowed to consume similar quantities on the night of the study.
Study 3: To confirm the findings of the initial comparison between home and laboratory studies, a further 16 patients used two oximeters simultaneously in the laboratory, and concurrently with full polysomnography. The second oximeter was used to simulate the home study, with the data being stored in the oximeter memory.
Analysis of Sleep Studies
The analysis of the oximetry data was performed using the CNS
SleepLab software. This was set to analyze the
SpO2 for dips of
4%. For each
analysis, the total number of dips, the averaged basal
SpO2, and the lowest recorded
SpO2 were obtained. The total time
for the study was obtained from the recorded download time and
corrected for periods of artifact. For the laboratory study, the total
time of recording, less artifact, was obtained. Dips per hour were
calculated for each study by dividing the total number of dips recorded
by the total time of the study.
Data Analysis
The data were analyzed using the Minitab statistics package
(release 12.23).11
To obtain the relationship
between the number of dips per hour from the home studies and the
number of dips per hour from the laboratory studies, linear regression
analysis was applied, its significance being established by analysis of
variance as applied to regression. To compare the two methods, the data
were analyzed using method comparison analysis.12
This
compares the difference between the measures from each method to the
mean of those measures. The mean difference between the two
measurements indicates the bias, and the SD of the differences
indicates the error between the two methods. The 95% confidence limits
for the estimates of the mean difference and the limits of agreement
(difference ± 2 SDs) were obtained. Differences were calculated as
(laboratory study - home study). From the data obtained, the
sensitivity and specificity of home oximetry studies were obtained
using cutoff points of 10/h13
and 15/h,
respectively.14
An ESS score of 0 to 10 was taken as a normal level of daytime sleepiness, while a score of > 14 was regarded as significant clinical daytime sleepiness. Data are presented as mean (range) unless otherwise stated.
| Results |
|---|
|
|
|---|
Study 1
In the 16 subjects studied, the mean number of hypoxic dips
using the CNS SleepLab analysis suite was 23.5/h (range, 4 to 103/h),
compared to 22.5/h (range, 5 to 109/h) from the BBC-B analysis. This
gave a mean dips per hour of 3.2/h (range, 0.6 to 13.8/h) and 3.1/h
(range, 0.7 to 14.3/h) for the CNS SleepLab and BBC-B analysis,
respectively. The relationship of the CNS SleepLab analysis to BBC-B
analysis was as follows: CNS SleepLab = 0.03 + (1.02 x BBC-B) ±
0.37 (r2 = 0.99, p < 0.001). The mean
difference was 0.1/h (SD, 0.36/h). The limits of agreement were
- 0.62 to 0.82/h, and the 95% confidence limits were - 0.1 to
0.3/h.
Study 2
Eighty-four patients were studied. All underwent full
polysomnography within 3 days of the home studies. The mean number of
4% dips for the home study was 35.9/h (range, 0 to 268/h) compared to
106/h (range, 0 to 897/h) for the laboratory study. This gave means of
5.3/h (range, 0 to 53/h) and 13.7/h (range, 0 to 106/h) for the home
study and laboratory study, respectively. The relationship of home
study to laboratory study was as follows: home = (0.4 x laboratory) -
0.01 ± 11.2 (r2 = 0.64,
p < 0.001). The differences were significantly correlated with
the mean of the measurements; the relationship was as follows:
difference = 1.14 - (0.76 x mean) ± 7.6
(r2 = 0.64, p < 0.001). There was
therefore a significant proportional bias with larger differences
occurring at higher mean values. This bias was removed when the
reciprocal of the difference was taken. Before transformation, the mean
difference was 8.4/h, the SD was 12.6/h, the limits of agreement were
16.8 to 33.6/h, and the 95% confidence limits were 5.6 to 11.1/h (Fig 1
). After transformation, the mean difference was 0.34/h, the SD was
1.02/h, the limits of agreement were 1.7 to 2.4/h, and the 95%
confidence intervals were 0.12 to 0.56/h.
|
In the 19 false-negative studies, seven patients had an ESS score
> 10, and four patients had an ESS score > 14. The mean ESS score
was 11.2 (range, 3 to 20). In the 13 positive studies, the mean ESS was
10 (range, 1 to 18); in the 52 negative studies, the mean ESS score was
10.6 (range, 0 to 24). The
2 test showed that
the distribution of ESS scores among the three groups was not
significantly different (
2 = 4.6; degrees of
freedom = 4)
When the cutoff point was increased to 15/h, 61 studies were both
negative and only 8 studies were both positive. Fifteen studies were
negative for home studies but positive for the laboratory studies. The
sensitivity was 0.35, while specificity remained unchanged. In the 15
false-negatives, the mean ESS score was 11.0 (range, 5 to 18); in the 8
positive studies, the mean ESS score was 11.8 (range, 3 to 20); and in
the 61 negative studies, mean ESS score was 10.2 (range, 0 to 24). The
2 test showed that the distribution of ESS
scores among the three groups was not significantly different
(
2 = 4.3; degrees of freedom = 4).
The averaged basal SpO2 values obtained from the home and laboratory studies were significantly different at 95% (86.6 to 98.2%) and 93.3% (85.4 to 96.4%), respectively (paired t test, p < 0.001). The lowest recorded SpO2 was 85.6% (51 to 94%) and 79% (30.7 to 91.7%) for the home and laboratory studies, respectively; these were also significantly different (p < 0.001).
From the full polysomnography studies, the mean number of apneas and hypopneas was 123 (range, 25 to 943), giving an apnea-hypopnea index of 15.9 events per hour (range, 4.1 to 111.4/h). The distribution of positive, negative, and false-negative studies was similar to that obtained using oximetry alone for a cutoff level of 15/h.
From these results, the patients who had negative findings on both home and laboratory studies and a normal ESS score did not have a trial of nasal continuous positive airway pressure (CPAP), while those who had positive findings on both studies underwent a trial of CPAP regardless of their ESS score. For the 19 false-negative studies, all patients underwent a trial of CPAP, of which six patients remained on CPAP at the end of the trial.
Study 3
Sixteen patients completed this study. The mean
SpO2 dips per hour was 3.2/h (range,
0.1 to 18.3/h) for stored data in the laboratory and 8.34/h (0.2 to
22.8/h) for the on-line recordings. The relationship of on-line data to
the stored data was as follows:
stored = (0.5 x on-line) - 1.17 ± 2.6
(r2 = 0.69, p < 0.001). The mean
difference was - 5.2h and the SD was 4.4/h (Fig 2
). The limits of agreement were - 3.6 to 14.0/h, and the 95%
confidence limits were - 2.8 to 7.6/h.
|
| Discussion |
|---|
|
|
|---|
The number of hypoxemic episodes detected from the home studies was less than one half the number detected during on-line recordings. This was not due to the analysis program used as the analysis of both the CNS SleepLab and the BBC-B systems gave almost identical results (study 1). It is also unlikely that the difference can be explained by (1) differences in the conditions under which the studies were made (oximetry only vs laboratory polysomnography), since the patients were in their own beds and had less equipment attached when at home, thereby favoring better sleep and hence more apneas; (2) an order effect of performing the home studies before the polysomnography studies; study 3 shows similar results to study 2, and although some of the differences between the results in study 2 may be explained by an order effect, this is probably small in comparison to the effects of different memory storage methods used in this study; and (3) signal quality. We could not ensure that signal quality was as good as that obtained in the laboratory, using the pulse waveform as a guide. The fact that the differences remained in study 3 suggests that this may have only contributed a minor degree to the differences observed in study 2.
The most likely explanation for the difference between the home and laboratory studies lies in that way in which the data were collected on the 2 nights, even when the two systems were used simultaneously in the laboratory (study 3). The memory store of the oximeters used in this study is built up by collecting the lowest arterial SpO2 during each 12-s period. In contrast, the on-line system collects data every 2 s. Although Warley et al7 have shown that short sampling time periods will detect transient hypoxemic episodes, it appears that collecting data every 12 s is not sufficient to detect all the hypoxemic episodes in patients with SAHS.
These findings reinforce previous work showing that pulse oximetry cannot be used to exclude SAHS. As well as the data storage problem shown in this study, which is particularly relevant to home studies, oximetry alone does not detect apneas and hypopneas that are not associated with hypoxemia.15 Furthermore, its use is restricted to patients who have a normal SpO2 when awake, since even normal hypoventilation during sleep causes oxygen desaturation in patients with preexisting hypoxemia.16
Nevertheless, many authors advocate the use of pulse oximetry in the diagnosis of SAHS,2 3 4 5 6 reserving more complex, more expensive, and less convenient investigations for patients in whom oximetry studies are inconclusive.17 18 Although pulse oximetry is less sensitive than polysomnography in detecting apneas and hypopneas,4 5 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 most cases of SAHS can be diagnosed from clinical history and oximetry. This was confirmed in our study, in which, using oximeter data alone and using a cutoff point of 10/h, no additional cases of SAHS would have been diagnosed using polysomnography rather than laboratory oximetry. Furthermore, there is increasing recognition that standard polysomnography is little or no better than oximetry alone in detecting clinically significant arousals from sleep,24 which are the main reason for treating sleep apnea.
To assess the possible clinical significance of the apparent false-negative home studies, we used the ESS to estimate the degree of daytime sleepiness. In the 19 false-negative studies (using a cutoff point of 10/h to diagnose SAHS), seven patients (37%) had an ESS score of > 10 and would therefore be regarded as having a high level of daytime sleepiness.8 Although this is consistent with the hypothesis that home oximetry missed more cases of clinically significant SAHS than on-line oximetry, these findings must be interpreted with caution, as in this study the ESS score was unable to distinguish between positive, false-negative, and true-negative findings. To further assess whether clinically significant SAHS had been missed, we determined how many patients responded to nasal CPAP. Using a cutoff point of 10/h, all of the 19 false-negative studies had a trial of CPAP, and six of these patients continued to use CPAP at the end of the trial. Thus, at least in these six patients (7% of the total), clinically significant SAHS would have been missed using home oximetry studies alone.
Since home oximetry consistently underestimates the number of hypoxemic episodes compared with online oximetry, a question which arises is whether the equation relating the two (home = (0.4 x on-line) - 0.01 ± 11.2) can be used to define a different cutoff point for the diagnosis of SAHS using home oximetry. Although the equation can be used as a guide, the wide confidence limits of the equation limit its usefulness, reflecting the fact that the home oximeter system is intrinsically less accurate than the laboratory system for this purpose, because of its inadequate storage system. Furthermore, this equation only applies to oximeters that use a 12-s memory storage facility. In our view, the best solution to this problem is to use an oximeter, which has better storage capabilities.
As well as affecting the clinical management of patients, these results may also have epidemiologic implications. Studies of prevalence have used oximeters with similar memory storage,24 and it is likely that they have underestimated the number of individuals with hypoxemic sleep apnea. Paradoxically, if this is true, it emphasizes the reason why oximetry is being used in many centers. The large number of patients being referred with suspected SAHS has made it necessary to use a system that is inexpensive and easy to use, ideally in the patients home.
Home oximetry, combined with a good clinical history, can have a useful place in the investigation of patients with suspected SAHS. However, the results of this study show that the data from home oximetry are dependent on the sampling rate of the memory storage system of the oximeter and are not identical to the data obtained in the sleep laboratory using on-line recordings. It is important that clinicians are aware of this when using oximetry for home assessments. Also, manufacturers need to be familiar with the clinical implications of different sampling rates used in oximeter memories, and to continue to improve them.
| Footnotes |
|---|
Received for publication August 23, 2000. Accepted for publication March 26, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. Hwang, N. Shakir, B. Limann, C. Sison, S. Kalra, L. Shulman, A. d. C. Souza, and H. Greenberg Association of Sleep-Disordered Breathing With Postoperative Complications Chest, May 1, 2008; 133(5): 1128 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Schlosshan and M W Elliott Sleep * 3: Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome Thorax, April 1, 2004; 59(4): 347 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Flemons, M. R. Littner, J. A. Rowley, P. Gay, W. M. Anderson, D. W. Hudgel, R. D. McEvoy, and D. I. Loube Home Diagnosis of Sleep Apnea: A Systematic Review of the Literature: An Evidence Review Cosponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society Chest, October 1, 2003; 124(4): 1543 - 1579. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |